panniculitis: a group of diseases whose hallmark is inflammation of subcutaneous adipose tissue (the fatty layer under the skin - panniculus adiposus). Symptoms include tender skin nodules, and systemic signs such as weight loss and fatigue.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
455 |
4. Check minimum number of eventsNone |
455 |
5. Include endpointsNone |
455 |
6. Filter based on genotype QC (FinnGen only) |
400 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M79
- Name in latin
- Panniculitis non specificata
Similar endpoints
↥List of similar endpoints to
Panniculitis, unspecified
based on the number of shared cases.
Similar with more cases:
- Other soft tissue disorders, not elsewhere classified
- Soft tissue disorders
- Pain (limb, back, neck, head abdominally)
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2209 | 1489 | 709 |
| Only index persons | 2001 | 1370 | 631 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 58.09 | 58.14 | 57.96 |
| Only index persons | 57.31 | 57.27 | 57.40 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 400 | 262 | 138 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.06 |
| Median age at first event (years) | 58.30 | 55.79 | 63.07 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 417
- Matched controls
- 4170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M79.3
ICD-10 Finland
Panniculitis, unspecified
4503599627370496.0
307.7
405
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
8.4
79.3
126
205
L52
ICD-10 Finland
Erythema nodosum
67.2
46.6
53
9
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
6.1
45.9
93
188
P01BA02
ATC
hydroxychloroquine; oral
5.8
34.5
70
140
M79.6
ICD-10 Finland
Pain in limb
3.4
32.9
214
994
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
31.8
80
193
A46
ICD-10 Finland
Erysipelas
4.0
30.4
105
322
H02AB06
ATC
prednisolone; systemic
3.2
30.1
251
1329
N02AX02
ATC
tramadol; systemic, rectal
3.1
28.6
219
1095
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
27.7
164
706
TQW80
NOMESCO Finland
Local dermatologic skincare
8.7
27.3
36
45
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.5
25.5
112
400
D07AD01
ATC
clobetasol; topical
3.4
25.1
112
404
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.9
24.3
191
948
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
24.2
242
1361
M13.9
ICD-10 Finland
Arthritis, unspecified
5.1
23.6
53
115
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.0
23.5
77
225
N03AX12
ATC
[U] gabapentin; oral
3.6
23.0
88
286
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
22.5
88
290
D07AC01
ATC
betamethasone; topical
2.7
22.0
199
1049
L04AX01
ATC
azathioprine; systemic
6.2
21.9
39
68
L04AX03
ATC
methotrexate; systemic
4.0
21.8
69
196
E66.8
ICD-10 Finland
Other obesity
5.2
21.1
46
97
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.4
21.1
90
313
M79.0
ICD-10 Finland
Rheumatism, unspecified
44.2
20.7
25
6
N03AX16
ATC
[U] pregabalin
2.9
19.9
116
483
M67.4
ICD-10 Finland
Ganglion
6.9
19.0
30
46
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.5
18.7
48
116
C03CA01
ATC
furosemide; systemic
2.6
18.5
152
751
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.8
18.5
120
527
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.8
17.7
58
168
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
17.2
118
530
M79.1
ICD-10 Finland
Myalgia
3.3
17.1
73
252
X59
ICD-10 Finland
Exposure to unspecified factor
2.9
17.0
94
377
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.3
16.9
72
248
A02BC02
ATC
pantoprazole; systemic
2.6
16.8
309
2174
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.8
16.8
99
411
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
12.9
16.6
29
24
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
15.1
16.6
27
19
J01MA02
ATC
ciprofloxacin; systemic
2.4
16.4
182
1021
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.7
16.4
56
167
UJF30
NOMESCO Finland
Ileoscopy through colon
3.4
16.3
65
215
J01FF01
ATC
clindamycin; systemic
2.5
16.0
135
668
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.9
16.0
37
82
7293X
ICD-9 Finland
Other disorders of soft tissues, Panniculitis, unspecified[PANNICULITIS NUD]
+∞
15.7
15
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.1
15.4
74
273
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.7
15.4
97
415
UJF32
NOMESCO Finland
Coloscopy
2.5
15.3
129
637
ZXA05
NOMESCO Finland
Left side
2.5
14.9
117
557
R50.9
ICD-10 Finland
Fever, unspecified
2.8
14.6
84
342
S97
ICPC
Chronic ulcer skin
3.9
14.4
44
121
S18
ICPC
Laceration/cut
2.2
14.2
217
1371
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
14.0
169
968
L01BA01
ATC
methotrexate; systemic
6.0
13.8
25
44
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.2
13.8
186
1113
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
13.7
189
1140
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.0
13.7
69
261
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
144.5
13.5
14
*
M25.5
ICD-10 Finland
Pain in joint
2.3
13.5
146
797
M76.6
ICD-10 Finland
Achilles tendinitis
5.0
13.5
30
64
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.6
13.5
48
147
L17
ICPC
Foot/toe symptom/complaint
2.3
13.4
142
768
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.8
13.3
42
118
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.2
13.2
36
91
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.0
13.1
64
238
M79.7
ICD-10 Finland
Fibromyalgia
13.6
13.1
22
17
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.0
13.0
38
101
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
13.0
59
210
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
13.0
53
177
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
6.0
12.9
23
40
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.6
12.9
45
136
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
12.9
128
673
J01DB01
ATC
cefalexin; oral
2.8
12.8
358
2850
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.0
12.8
64
241
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
12.7
105
508
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.7
12.7
24
44
J01MA12
ATC
levofloxacin; systemic
2.5
12.6
92
420
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
6.5
12.6
21
34
E0000UV, ,
ATC
2.1
12.4
197
1242
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
12.4
64
245
M02AA07
ATC
piroxicam; topical
2.2
12.3
155
895
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.3
12.2
21
35
B01AB05
ATC
enoxaparin; parenteral
2.2
12.2
150
857
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.1
12.1
26
54
SPAT1153
SPAT
Removal of sutures
2.2
11.8
139
778
M01AH05
ATC
etoricoxib; oral
2.1
11.8
266
1898
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
5.8
11.8
22
40
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
11.6
59
224
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
8.7
11.5
24
29
N06AX21
ATC
duloxetine; oral
2.9
11.4
58
220
M54.5
ICD-10 Finland
Low back pain
2.1
11.4
151
884
H02AB04
ATC
methylprednisolone; systemic
2.6
11.3
72
307
L14
ICPC
Leg/thigh symptom/complaint
3.3
11.3
46
153
ZXA00
NOMESCO Finland
Right side
2.2
11.2
120
645
SPAT1263
SPAT
Sampling
2.0
11.2
184
1165
R03AC02
ATC
salbutamol; inhalant
2.0
11.1
239
1664
E000001, ,
ATC
2.3
11.0
95
466
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
11.0
117
628
J01DA01
ATC
[U] cefalexin
2.0
10.9
263
1899
M54.1
ICD-10 Finland
Radiculopathy
4.9
10.8
24
51
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.2
10.8
120
653
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.7
10.8
36
105
A02BC05
ATC
esomeprazole; systemic
2.0
10.8
175
1099
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
10.8
125
693
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
10.7
91
443
R52.2
ICD-10 Finland
Other chronic pain
5.0
10.6
23
48
P01AB01
ATC
metronidazole; oral, rectal
2.0
10.5
180
1148
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
10.5
104
541
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
10.5
10
*
N06AA09
ATC
amitriptyline; systemic
3.1
10.5
47
166
M75.3
ICD-10 Finland
Calcific tendinitis of shoulder
33.5
10.4
13
*
T90
ICPC
Diabetes non-insulin dependent
2.2
10.3
116
633
R51.80
ICD-10 Finland
Headache
2.4
10.2
76
348
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
7.9
10.0
22
29
M54.3
ICD-10 Finland
Sciatica
3.7
10.0
32
91
R60.0
ICD-10 Finland
Localized oedema
2.6
10.0
62
261
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.3
9.9
20
39
M48.0
ICD-10 Finland
Spinal stenosis
2.8
9.9
53
206
M54.4
ICD-10 Finland
Lumbago with sciatica
2.4
9.9
78
367
A02BC01
ATC
omeprazole; systemic
2.1
9.9
120
674
M79.9
ICD-10 Finland
Soft tissue disorder, unspecified
26.7
9.9
13
5
R52.9
ICD-10 Finland
Pain, unspecified
2.9
9.9
50
189
M05BA04
ATC
alendronic acid; oral
2.9
9.8
50
190
WX002
NOMESCO Finland
Sedation and analgesia
2.3
9.7
87
432
NF1AA
NOMESCO Finland
Hip X-ray examination
3.0
9.6
44
157
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.0
9.6
45
163
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.3
9.6
80
386
H02AB07
ATC
prednisone; oral
2.5
9.5
63
273
R42
ICD-10 Finland
Dizziness and giddiness
2.1
9.5
107
583
L16
ICPC
Ankle symptom/complaint
2.6
9.4
57
236
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
9.0
9.4
19
22
M01AC06
ATC
meloxicam; systemic, rectal
1.9
9.4
157
986
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
9.4
124
717
M70.6
ICD-10 Finland
Trochanteric bursitis
2.6
9.4
57
237
SPAT1262
SPAT
Handing over of treatment supplies
2.3
9.3
82
405
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
9.2
119
681
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.8
9.2
47
178
L04AA06
ATC
mycophenolic acid; systemic
8.6
9.2
19
23
L28
ICPC
Limited function/disability (L)
2.2
9.0
83
416
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.8
8.9
47
181
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.6
8.9
30
88
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
8.9
154
974
R20.2
ICD-10 Finland
Paraesthesia of skin
3.4
8.8
33
104
L86
ICPC
Back syndrome with radiating pain
3.4
8.8
32
99
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.4
8.8
66
303
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
8.8
83
421
L88
ICD-10 Finland
Pyoderma gangrenosum
51.1
8.7
10
*
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.8
8.7
27
75
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
4.2
8.6
23
57
M01AH01
ATC
celecoxib; oral
2.2
8.5
77
383
Z71.8
ICD-10 Finland
Other specified counselling
1.9
8.4
149
946
R06.0
ICD-10 Finland
Dyspnoea
2.0
8.4
113
654
L08
ICPC
Shoulder symptom/complaint
2.1
8.4
91
487
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.0
8.4
24
63
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.3
8.2
71
346
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
8.2
45
177
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.0
8.2
105
596
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
8.2
29
88
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.5
8.2
29
88
N02BF01
ATC
gabapentin; oral
2.8
8.1
43
166
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
8.1
114
669
N02BE01
ATC
paracetamol; systemic, rectal
2.6
8.1
375
3239
J01FA06
ATC
roxithromycin; oral
1.8
8.1
168
1119
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
2.5
8.1
53
228
L15
ICPC
Knee symptom/complaint
2.0
8.1
111
646
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
8.1
46
185
A01AB09
ATC
miconazole; local oral
2.7
8.0
43
168
D02
ICPC
Abdominal pain epigastric
3.2
7.9
32
106
SPAT1255
SPAT
Intravenous administration of medicine
3.2
7.9
32
106
AA1AD
NOMESCO Finland
CT of head and brain
1.9
7.9
124
755
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
7.9
200
1414
A01AB04
ATC
amphotericin B; local oral
3.5
7.8
27
81
S04
ICPC
Lump/swelling localized
2.5
7.8
52
226
ZXD05
NOMESCO Finland
Urgent procedure
1.9
7.8
127
783
R10.0
ICD-10 Finland
Acute abdomen
4.5
7.8
19
44
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
7.7
58
266
L29
ICPC
Musculoskeletal sympt/complt other
2.7
7.7
42
165
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
7.7
24
67
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
18.8
7.6
11
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
7.6
44
178
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
9.1
7.6
15
17
G72.9
ICD-10 Finland
Myopathy, unspecified
25.5
7.6
10
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.5
7.6
50
216
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.0
7.6
34
120
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
7.6
34
120
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
7.6
69
344
SPAT1229
SPAT
Assessment of need for aid
3.0
7.5
34
121
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.5
7.5
51
224
M01AX17
ATC
nimesulide; oral
2.0
7.5
96
545
Z01.2
ICD-10 Finland
Dental examination
1.8
7.4
189
1330
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
8.6
7.4
15
18
S22.3
ICD-10 Finland
Fracture of rib
2.8
7.4
38
145
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
7.3
92
519
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.7
7.2
23
65
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.8
7.2
36
135
NDM20
NOMESCO Finland
Excision of synovial ganglion of wrist or hand
30.6
7.2
9
*
N02BF02
ATC
pregabalin; oral
3.0
7.2
31
107
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.7
7.2
40
159
M04AA01
ATC
allopurinol; systemic
2.3
7.2
57
268
A02BA02
ATC
ranitidine; systemic
2.0
7.2
82
446
C07AB07
ATC
bisoprolol; oral
1.7
7.1
203
1469
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
7.1
72
373
M01CB01
ATC
sodium aurothiomalate; parenteral
12.3
7.1
12
10
D06
ICPC
Abdominal pain localized other
2.6
7.1
42
172
A01
ICPC
Pain general/multiple sites
2.5
7.1
44
185
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
7.1
100
586
J45.8
ICD-10 Finland
Mixed asthma
4.5
7.0
17
39
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
7.0
45
192
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
6.0
7.0
18
31
H01
ICPC
Ear pain/earache
2.3
7.0
53
244
M01AE02
ATC
naproxen; oral, rectal
1.7
7.0
230
1731
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
7.0
101
596
M03BC51
ATC
orphenadrine, combinations; systemic
1.9
7.0
115
708
K10.3
ICD-10 Finland
Alveolitis of jaws
3.4
6.9
25
77
Z3226
NOMESCO Finland
Physiotherapist
2.1
6.9
72
377
M01AX01
ATC
nabumetone; oral
3.6
6.9
23
67
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
6.9
32
115
A10AE04
ATC
insulin glargine; parenteral
2.4
6.9
48
213
N02AA05
ATC
oxycodone; systemic
2.1
6.9
76
408
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
6.9
34
127
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
6.8
49
220
WVA20
NOMESCO Finland
Medicine administration
4.4
6.8
17
40
WX320
NOMESCO Finland
Spinalanesthesy
1.9
6.8
103
616
J01AA02
ATC
doxycycline; systemic
1.9
6.8
317
2626
E66.9
ICD-10 Finland
Obesity, unspecified
3.5
6.8
23
68
L03
ICPC
Low back symptom/complaint
1.9
6.8
113
697
R4110
NOMESCO Finland
Physiotherapy
1.8
6.8
117
730
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.7
6.7
180
1275
A02BC03
ATC
lansoprazole; oral
1.8
6.7
117
732
M71.2
ICD-10 Finland
Synovial cyst of popliteal space [Baker]
4.1
6.7
18
45
R01AD08
ATC
fluticasone; nasal
1.8
6.7
118
741
J02AC01
ATC
fluconazole; systemic
1.7
6.7
164
1134
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.2
6.7
63
318
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
6.7
82
457
R03BA02
ATC
budesonide; inhalant
2.0
6.7
80
442
R06AX27
ATC
desloratadine; oral
1.8
6.7
120
758
A10BK03
ATC
empagliflozin; oral
2.3
6.6
51
236
A10BA02
ATC
metformin; oral
1.8
6.6
122
775
R60.9
ICD-10 Finland
Oedema, unspecified
3.0
6.6
29
101
S21
ICPC
Skin texture symptom/complaint
2.1
6.6
68
355
M03BX02
ATC
tizanidine; oral
1.7
6.6
250
1943
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
8.9
6.6
13
15
M65.3
ICD-10 Finland
Trigger finger
6.4
6.5
16
26
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
6.5
253
1976
H02AB09
ATC
hydrocortisone; systemic
5.9
6.5
17
30
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.8
6.5
32
119
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.0
6.5
29
102
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
7.6
6.5
14
19
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.6
6.5
14
19
D07AC13
ATC
mometasone; topical
1.8
6.5
126
814
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
6.4
114
715
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
3.9
6.4
19
51
J04BA02
ATC
dapsone; oral
14.6
6.4
10
7
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
6.4
105
643
S01
ICPC
Pain/tenderness of skin
3.4
6.4
23
71
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
8.3
6.4
13
16
M01AB05
ATC
diclofenac; systemic, rectal
1.7
6.3
261
2064
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
11.3
6.3
11
10
A08
ICPC
Swelling
2.8
6.3
32
121
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.9
6.3
86
496
J01CA04
ATC
amoxicillin; systemic
1.9
6.3
334
2837
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
6.3
152
1042
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
6.3
166
1166
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
6.3
60
304
XF600
NOMESCO Finland
Bloodpressure measurement
3.0
6.3
27
93
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
3.8
6.3
19
52
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
6.3
48
222
ZXA10
NOMESCO Finland
Bilateral
2.0
6.2
77
429
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.3
6.2
49
229
D07AB02
ATC
hydrocortisone butyrate; topical
1.8
6.2
125
813
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
6.2
26
88
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.1
6.2
17
43
Z3231
NOMESCO Finland
Registered nurse
1.8
6.2
113
714
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.9
6.2
86
499
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.4
6.2
42
184
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.8
6.2
108
674
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
6.2
27
94
M01AE01
ATC
ibuprofen; systemic, rectal
2.2
6.1
373
3301
M01AH02
ATC
rofecoxib; oral
2.2
6.1
53
258
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.5
6.1
39
166
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.6
6.1
20
58
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.6
6.1
20
58
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.6
6.1
20
58
L02
ICPC
Back symptom/complaint
2.3
6.1
48
225
S06
ICPC
Rash localized
3.0
6.1
27
95
A07AA02
ATC
nystatin; oral
3.0
6.1
27
95
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
6.0
76
426
G47.3
ICD-10 Finland
Sleep apnoea
1.9
6.0
91
542
OAB50, ,
SPAT
2.5
6.0
39
167
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
6.0
75
419
N05CF01
ATC
zopiclone; oral
1.7
6.0
134
897
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
68
116
6.81
39.57
1.5
1.5
0.19
0.13
iu/ml
0.14
19
19
69
141
5.67
33.20
2.1
1.5
9.18
8.96
iu/ml
0.01
22
32
63
133
5.40
29.11
1.4
1.1
3.32
2.55
u/ml
—
5
11
316
1995
3.41
26.60
14.2
10.0
4.37
4.09
e9/l
1.38
291
1736
180
833
3.04
26.57
3.4
2.7
345.07
343.35
umol/l
0.07
158
728
266
1564
2.94
24.60
6.8
4.8
34.89
35.74
g/l
1.65
252
1468
281
1757
2.84
22.13
9.3
7.0
1.21
1.21
mmol/l
0.35
255
1507
288
1830
2.85
21.87
8.4
6.7
9.90
11.55
umol/l
2.93
278
1744
106
411
3.12
20.68
2.3
2.7
88.07
140.20
ug/g
1.71
87
321
35
58
6.50
20.64
1.3
1.1
174.17
208.00
titre
—
6
5
213
1195
2.60
20.30
4.8
3.0
—
—
—
0
0
132
595
2.78
19.44
1.5
1.3
40.71
37.00
iu/ml
0.13
36
189
196
1077
2.55
19.24
4.6
2.4
103.05
71.85
u/l
0.50
188
996
350
2559
3.29
18.92
8.6
3.9
17.38
12.29
mm/h
6.08
336
2368
360
2686
3.49
18.57
13.6
8.0
77.99
79.39
u/l
0.31
349
2537
121
538
2.76
18.14
1.6
1.2
11.78
12.94
u/ml
0.06
44
200
44
102
4.70
18.03
2.4
2.7
—
—
—
0
0
123
555
2.73
17.89
2.8
2.4
11.93
12.95
umol/l
0.84
118
518
176
947
2.49
17.74
3.9
2.9
0.26
0.44
e6/l
1.17
145
695
193
1093
2.43
17.26
4.7
3.0
14.72
67.92
e6/l
2.93
163
839
75
263
3.26
17.12
2.2
3.0
66.44
67.03
g/l
0.24
68
249
247
1570
2.41
16.87
3.2
2.8
—
—
estimate
—
0
0
248
1602
2.35
16.00
18.3
11.1
0.00
0.00
e9/l
0.17
213
1320
244
1568
2.34
15.90
7.7
6.2
1.21
1.21
mmol/l
0.01
238
1440
34
72
5.05
15.47
1.2
1.2
—
—
—
0
0
110
512
2.56
14.71
2.7
2.4
2.41
2.33
g/l
0.81
104
472
241
1575
2.26
14.62
22.7
14.1
1.26
1.24
inr
0.15
214
1302
142
755
2.34
14.08
3.7
2.4
4.50
7.08
e6/l
1.41
129
684
79
321
2.80
13.77
2.5
1.9
336.61
388.35
nmol/l
1.73
74
299
267
1846
2.24
13.75
6.2
3.7
23.79
0.00
estimate
0.49
62
395
200
1237
2.19
13.61
3.5
3.7
2.34
2.36
mmol/l
1.34
190
1131
136
726
2.30
13.23
2.0
1.5
0.74
1.33
mg/l
3.98
114
560
238
1589
2.16
13.17
3.2
2.4
75.75
77.83
nmol/l
0.51
222
1442
100
468
2.50
13.07
2.8
2.5
20.44
22.53
%
0.76
92
436
263
1830
2.18
13.02
6.1
3.7
0.00
0.00
estimate
0.50
61
390
206
1312
2.13
12.76
4.7
3.5
34.50
39.43
ng/l
0.16
151
922
58
207
3.09
12.72
1.3
1.2
78.88
287.44
u/ml
1.10
52
190
194
1214
2.12
12.52
3.8
3.2
7.47
7.48
mmol/l
0.01
165
1031
264
1867
2.13
12.17
6.3
3.7
0.00
0.01
estimate
0.65
57
371
186
1163
2.08
11.86
3.6
3.2
29.99
31.69
u/l
0.41
180
1103
111
576
2.26
11.33
2.8
2.7
1.13
1.04
e6/l
0.10
73
308
185
1172
2.04
11.22
4.9
4.0
8.74
7.82
mg/mmol
0.11
123
715
164
996
2.07
11.16
3.4
3.1
1261.16
1425.99
ng/l
0.21
147
842
167
1022
2.06
11.12
6.6
3.9
0.00
0.01
estimate
0.74
56
366
18
13
14.41
11.07
1.6
4.1
1751.78
753.77
u/ml
0.53
18
13
74
324
2.56
11.01
3.8
2.1
30.88
39.08
u/l
0.86
60
281
235
1641
1.99
10.62
4.0
2.9
126.65
121.70
ug/l
0.13
225
1518
144
860
2.03
10.06
3.2
2.2
3.10
3.04
mg/l
0.09
131
725
81
385
2.37
10.05
3.4
2.6
4.85
7.00
umol/l
2.66
74
342
58
235
2.71
10.04
2.0
1.7
—
—
—
0
0
105
558
2.18
9.98
2.1
1.9
—
—
—
0
0
220
1524
1.94
9.95
2.5
2.0
98.18
96.79
pmol/l
0.17
141
793
100
523
2.20
9.88
3.8
2.9
3.28
2.87
e6/l
0.16
64
257
133
776
2.05
9.88
1.4
1.3
1.81
1.95
u/ml
0.04
46
209
272
2036
1.97
9.63
6.4
4.8
6.97
6.66
mmol/l
1.50
266
1913
26
67
4.07
9.28
1.5
1.2
70.52
28.60
u/ml
—
6
11
31
94
3.48
8.80
1.7
1.2
—
—
—
0
0
201
1405
1.83
8.36
6.2
3.7
0.00
0.03
estimate
1.39
49
328
26
73
3.73
8.26
1.8
1.7
9308.24
19555.14
e6/l
0.63
17
56
121
725
1.94
8.11
2.9
2.7
2.46
2.45
mmol/l
0.56
110
662
99
556
2.02
7.97
2.0
1.7
1165.24
1220.81
nmol/l
0.27
87
411
132
822
1.89
7.83
2.8
2.3
—
—
—
0
0
104
598
1.98
7.82
1.7
1.5
—
—
—
0
0
28
86
3.42
7.80
1.3
1.1
—
—
—
0
0
28
86
3.42
7.80
1.3
1.1
—
—
—
0
0
26
77
3.53
7.65
1.4
1.5
—
—
—
0
0
126
785
1.87
7.41
6.7
3.9
1.02
1.02
kg/l
1.36
94
524
24
69
3.63
7.38
1.7
1.5
—
—
—
0
0
333
2784
1.97
7.20
5.3
4.2
14.95
14.79
pmol/l
0.60
318
2527
76
403
2.08
7.10
1.8
1.8
—
—
—
0
0
388
3473
2.69
6.55
31.5
14.2
21.60
25.05
mg/l
1.61
356
2782
293
2388
1.76
6.43
4.3
3.1
50.22
49.31
u/l
0.07
281
2238
30
109
2.89
6.36
1.7
1.6
35.97
6.51
u/ml
—
7
22
265
2104
1.71
6.35
2.9
2.9
—
—
—
0
0
19
52
3.78
6.27
1.3
1.5
147.80
152.34
au/ml
—
5
16
41
177
2.46
6.22
4.1
3.0
1.46
2.03
mmol/l
0.45
28
129
372
3286
2.22
6.19
6.8
5.1
1.91
1.94
mu/l
0.24
357
3010
16
29
5.69
6.05
1.1
1.1
—
—
—
0
0
69
374
2.01
6.04
7.2
8.9
1.27
1.28
mmol/l
0.01
62
310
39
167
2.47
6.03
1.7
1.3
—
—
—
0
0
37
155
2.52
5.98
1.3
1.3
—
—
—
0
0
25
85
3.06
5.95
1.5
2.0
566.36
5015.60
u/l
—
10
28
16
30
5.50
5.90
1.7
1.0
—
—
—
0
0
395
3597
2.86
5.86
30.4
16.7
139.69
139.71
mmol/l
0.07
390
3512
395
3606
2.81
5.66
30.8
16.9
3.95
3.96
mmol/l
0.03
390
3510
69
385
1.95
5.55
2.0
1.8
—
—
—
0
0
23
78
3.06
5.50
2.2
1.6
—
—
—
0
0
14
25
5.76
5.42
1.1
1.2
—
—
—
0
0
146
1031
1.64
5.22
5.2
3.2
0.00
0.01
estimate
0.99
50
301
34
148
2.41
5.09
1.5
1.7
1.42
1.52
g/l
0.31
29
132
96
611
1.74
5.05
4.9
3.7
68.49
370.42
ng/l
2.43
73
478
26
101
2.68
4.90
3.0
3.6
24.39
25.13
mmol/l
0.58
26
96
53
282
2.01
4.87
3.0
3.0
79.76
78.51
ng/l
0.04
46
246
25
97
2.68
4.73
1.6
1.4
268.63
299.56
ug/g
0.32
19
55
111
755
1.64
4.52
1.9
1.8
461.07
18425637.13
pmol/l
0.50
95
635
22
83
2.74
4.39
1.5
1.7
—
—
—
0
0
10
16
6.37
4.31
1.8
1.1
—
—
—
0
0
19
67
2.92
4.28
1.2
1.2
153.77
251.55
u/ml
1.53
13
38
10
17
6.00
4.15
1.2
1.8
13.20
14.47
%
—
10
17
20
75
2.75
4.05
1.2
1.2
—
—
—
0
0
23
93
2.56
4.04
1.1
1.3
—
—
—
0
0
367
3334
1.84
4.03
9.2
6.0
41.23
39.11
mmol/mol
4.07
355
3108
35
172
2.13
3.98
3.3
3.1
25.24
25.00
mmol/l
0.20
35
167
42
223
1.98
3.90
3.4
2.8
118.50
130.08
g/l
2.40
42
216
11
23
4.88
3.89
1.7
1.0
—
—
—
0
0
11
23
4.88
3.89
1.7
1.0
—
—
—
0
0
21
83
2.61
3.86
1.2
1.3
—
—
—
0
0
10
19
5.36
3.85
1.3
1.9
—
—
—
0
0
11
24
4.68
3.77
1.7
1.0
—
—
—
0
0
11
24
4.68
3.77
1.7
1.0
—
—
—
0
0
37
190
2.04
3.76
1.8
1.7
—
—
—
0
0
13
34
3.91
3.72
2.0
1.4
—
—
—
0
0
13
34
3.91
3.72
2.0
1.4
—
—
—
0
0
22
92
2.47
3.62
1.7
1.3
—
—
—
0
0
13
35
3.80
3.62
2.0
1.4
—
—
—
0
0
37
194
2.00
3.56
2.5
2.3
0.71
0.64
%
0.58
37
194
34
173
2.05
3.55
10.3
13.2
15.27
15.62
%
0.32
34
167
11
26
4.32
3.53
1.7
1.0
—
—
—
0
0
13
36
3.69
3.52
2.1
1.4
—
—
—
0
0
371
3415
1.78
3.43
25.8
13.8
79.93
81.02
ml/min/173m2
0.47
358
3166
13
37
3.59
3.43
2.1
1.4
—
—
—
0
0
13
37
3.59
3.43
2.1
1.4
—
—
—
0
0
27
129
2.17
3.32
1.7
1.9
—
—
—
0
0
396
3730
2.22
3.31
21.5
11.3
27.59
25.34
u/l
1.52
391
3609
133
1006
1.47
3.24
2.0
1.6
18.23
20.20
nmol/l
0.92
124
842
8
15
5.41
3.20
2.1
1.7
57.04
55.17
ug/l
—
8
15
24
113
2.19
3.07
2.1
1.6
—
—
—
0
0
58
372
1.65
2.93
4.5
3.3
—
—
—
0
0
14
53
2.70
2.82
2.0
1.3
—
—
—
0
0
8
18
4.51
2.81
1.0
2.1
103.87
99.78
%
—
8
18
10
28
3.63
2.80
2.6
4.1
894.20
983.04
mg
—
10
28
22
104
2.18
2.80
3.5
3.6
1.49
6.30
ratio
0.70
16
57
5
6
8.41
2.75
1.0
1.0
—
—
—
0
0
19
85
2.29
2.74
3.3
2.0
128.15
131.23
g/l
0.23
13
69
6
10
6.07
2.70
1.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
6
10
6.07
2.70
1.0
1.0
99.67
105.70
%
—
6
10
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
99
2.18
2.69
2.6
2.5
0.30
0.36
iu/ml
0.53
14
56
181
1490
1.38
2.64
2.0
1.9
1.48
1.33
mmol/l
1.41
159
1248
7
15
4.73
2.60
2.1
1.3
—
—
—
0
0
7
15
4.73
2.60
2.1
1.3
—
—
—
0
0
12
42
2.91
2.57
2.6
2.8
—
—
—
0
0
5
7
7.21
2.55
1.0
1.0
—
—
—
0
0
15
64
2.39
2.41
2.5
3.1
0.71
0.93
nmol/l
—
10
53
14
58
2.46
2.39
1.2
1.1
1.00
22.91
iu/ml
—
5
11
59
403
1.54
2.31
1.6
1.8
1.56
1.48
%
0.36
51
352
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
13
4.67
2.28
1.0
2.4
163.33
119.08
%
—
6
13
373
3510
1.59
2.26
5.9
5.0
4.47
4.70
mmol/l
3.86
358
3259
20
100
2.05
2.24
1.5
1.6
93.15
93.27
%
0.01
20
95
366
3433
1.54
2.21
6.6
4.9
6.19
5.91
mmol/l
2.93
354
3125
23
122
1.94
2.21
1.6
1.8
—
—
—
0
0
371
3492
1.57
2.19
5.8
4.9
1.37
1.49
mmol/l
7.39
355
3223
16
74
2.21
2.17
1.5
1.5
—
—
—
0
0
41
261
1.63
2.16
3.0
2.2
4.27
7.35
ug/l
1.06
35
223
6
14
4.33
2.16
2.3
1.4
—
—
—
0
0
6
14
4.33
2.16
2.3
1.4
—
—
—
0
0
377
3567
1.59
2.10
6.6
5.6
2.58
2.75
mmol/l
2.61
362
3301
56
387
1.52
2.09
10.4
6.8
—
—
—
0
0
22
118
1.91
2.06
1.4
1.4
190.96
237.84
miu/ml
—
9
58
8
26
3.12
2.02
1.1
1.3
—
—
—
0
0
12
51
2.39
1.96
1.1
1.0
—
—
—
0
0
8
28
2.89
1.87
1.0
1.1
107.13
109.46
pmol/l
—
8
28
18
94
1.96
1.83
1.4
1.6
—
—
—
0
0
5
12
4.20
1.83
1.2
1.0
—
—
—
0
0
12
53
2.30
1.82
1.4
1.6
—
—
—
0
0
9
35
2.61
1.81
1.7
1.1
—
—
—
0
0
9
35
2.61
1.81
2.4
2.3
—
—
—
0
0
356
3351
1.43
1.80
5.0
4.2
1.44
1.27
mmol/l
3.49
342
3078
12
54
2.26
1.75
1.2
1.2
1.60
1.82
u/ml
—
5
17
9
36
2.53
1.75
2.4
2.2
—
—
—
0
0
53
379
1.46
1.70
4.2
4.6
2.93
38.07
ug/l
1.01
45
312
17
90
1.93
1.67
1.4
1.3
—
—
—
0
0
8
31
2.61
1.66
1.6
1.8
—
—
—
0
0
8
31
2.61
1.66
1.6
1.8
—
—
—
0
0
8
31
2.61
1.66
1.6
1.8
—
—
—
0
0
6
19
3.19
1.66
3.3
5.5
73.00
184.21
nmol/l
—
6
19
40
272
1.52
1.64
6.5
2.9
67.53
62.09
ml/min/173m2
0.32
19
120
13
63
2.10
1.61
2.1
1.9
—
—
—
0
0
10
43
2.36
1.60
1.4
1.3
—
—
—
0
0
5
15
3.36
1.52
1.0
1.0
—
—
—
0
0
5
15
3.36
1.52
1.2
1.5
—
—
—
0
0
5
15
3.36
1.52
1.2
1.5
—
—
—
0
0
15
79
1.93
1.51
1.3
1.3
—
—
—
0
0
13
65
2.03
1.50
5.2
3.6
10.61
9.60
pmol/l
0.13
13
65
15
80
1.91
1.46
1.5
1.5
—
—
—
0
0
5
16
3.15
1.44
1.4
1.8
—
—
—
0
0
5
16
3.15
1.44
1.4
1.8
—
—
—
0
0
5
16
3.15
1.44
1.4
1.8
—
—
—
0
0
5
16
3.15
1.44
4.8
3.6
1.40
0.81
%
—
5
16
5
16
3.15
1.44
1.4
1.8
—
—
—
0
0
13
67
1.97
1.39
1.5
1.5
—
—
—
0
0
6
23
2.63
1.37
2.8
2.2
31.33
36.00
mg/l
—
6
17
5
18
2.80
1.29
1.2
1.5
112.50
87.46
ng/l
—
5
18
8
35
2.31
1.27
1.8
1.2
—
—
—
0
0
6
25
2.42
1.25
1.3
1.3
—
—
—
0
0
37
266
1.43
1.19
2.0
1.5
—
—
—
0
0
10
51
1.98
1.12
2.0
2.6
1.22
1.18
mmol/l
—
10
51
5
21
2.40
1.09
1.8
1.5
—
—
—
0
0
10
52
1.95
1.07
2.0
2.6
107.10
105.46
mmol/l
—
10
52
29
397
0.71
0.99
1.9
2.0
3.91
3.51
ratio
0.51
18
327
5
23
2.19
0.98
1.0
1.0
—
—
—
0
0
16
100
1.62
0.98
2.3
1.7
—
—
—
0
0
9
51
1.78
0.95
1.0
1.1
—
—
—
0
0
11
62
1.80
0.95
1.4
1.1
—
—
—
0
0
11
62
1.80
0.95
1.4
1.1
—
—
—
0
0
17
111
1.55
0.89
1.2
1.7
—
—
—
0
0
8
43
1.88
0.87
1.1
1.7
—
—
—
0
0
8
138
0.57
0.85
1.0
1.1
1.53
1.56
g/l
—
8
138
6
31
1.95
0.84
1.2
1.5
—
—
—
0
0
6
31
1.95
0.84
1.5
1.5
—
—
—
0
0
8
140
0.56
0.84
1.0
1.2
1.00
0.90
g/l
—
8
140
33
250
1.35
0.83
1.2
1.2
47.81
137.42
u/ml
2.69
12
99
8
46
1.75
0.83
1.1
1.5
65.06
47.89
ug/l
—
8
46
8
46
1.75
0.83
1.3
1.6
—
—
—
0
0
20
278
0.71
0.77
1.8
1.8
3.85
3.47
mmol/l
—
10
209
105
923
1.18
0.76
4.8
5.2
1.57
2.38
ug/l
1.39
97
826
9
53
1.71
0.76
1.2
1.5
—
—
—
0
0
5
25
2.01
0.73
1.2
1.2
190.46
292.47
u/l
—
5
25
5
25
2.01
0.73
1.2
1.5
—
—
—
0
0
28
212
1.34
0.72
2.3
2.7
135.07
105.89
u/ml
0.11
28
205
15
101
1.50
0.71
1.8
1.4
—
—
—
0
0
5
28
1.79
0.66
3.2
2.8
—
—
—
0
0
38
309
1.25
0.61
2.2
2.1
—
—
—
0
0
11
72
1.54
0.59
1.1
1.1
—
2.98
—
0
11
41
338
1.24
0.59
2.3
2.2
—
—
—
0
0
6
39
1.55
0.53
2.7
4.3
2.42
2.67
nmol/l
—
6
39
25
197
1.29
0.52
2.6
2.1
—
—
—
0
0
21
163
1.30
0.49
1.1
1.0
—
—
—
0
0
5
31
1.62
0.43
1.2
1.3
—
—
—
0
0
65
580
1.14
0.41
1.5
1.5
—
—
—
0
0
5
35
1.43
0.39
1.2
1.4
—
—
—
0
0
18
142
1.28
0.39
1.3
1.5
0.21
0.26
mg/l
—
8
62
81
738
1.12
0.38
3.8
4.4
24.80
21.09
%
1.40
36
337
61
546
1.14
0.38
2.8
3.1
0.63
0.78
ug/l
1.07
40
347
21
171
1.24
0.36
2.6
2.0
—
—
—
0
0
6
41
1.47
0.36
1.3
1.1
—
—
—
0
0
7
55
1.28
0.30
2.7
1.9
—
—
—
0
0
298
2911
1.08
0.29
35.2
18.5
330.21
331.92
g/l
2.78
298
2891
10
76
1.32
0.28
2.7
2.4
47.24
67.38
ug/min
—
5
43
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
405.84
—
0
5
7
62
1.13
0.17
1.6
1.7
—
—
—
0
0
16
141
1.14
0.14
1.3
1.6
—
—
—
0
0
13
114
1.14
0.12
7.0
2.9
1.75
1.47
mg/l
0.55
13
105
11
97
1.14
0.09
2.6
2.0
3.37
5.55
iu/l
—
5
45
45
431
1.05
0.08
5.8
4.8
31.41
31.69
%
0.06
34
285
11
98
1.13
0.07
2.6
1.8
49.91
40.50
nmol/l
0.42
11
98
15
143
1.05
0.01
1.6
1.9
4.35
7.46
mg/l
0.38
15
109
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
6.17
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
69.70
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.18
—
0
5
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_PANNICULITISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PANNICULITISNAS | 1.38 [1.15, 1.66] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.527 |
During the follow-up period (1.1.1998 — 31.12.2019), 280 out of 1244 females with M13_PANNICULITISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_PANNICULITISNAS | 1.738 [1.29, 2.34] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 139 out of 552 males with M13_PANNICULITISNAS died.
Mortality risk
Mortality risk for people of age
years, who have M13_PANNICULITISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.178% | 0.309% |
| 5 | 0.897% | 1.926% |
| 10 | 2.107% | 4.525% |
| 15 | 4.121% | 8.675% |
| 20 | 7.064% | 14.637% |
Relationships between endpoints
↥Index endpoint: M13_PANNICULITISNAS – Panniculitis, unspecified
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data